Key Insights

Highlights

Success Rate

33% trial completion

Treatment Research

4 treatments under study, led by Radiofrequency Catheter Ablation

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

50.0%

2 terminated out of 4 trials

Success Rate

33.3%

-53.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results33% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 1 (1)
Phase 1/2 (1)

Trial Status

Terminated2
Completed1
Recruiting1

Trial Success Rate

33.3%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Radiofrequency Catheter Ablation1
  • Paddleshaped Highdensity Multielectrode Mapping Catheter1
  • Therapy Cool Path Duo Cardiac Ablation System1
  • Dynamic Substrate Mappingguided Ablation1

Active Sponsors

  • Biosense Webster, Inc.2
  • Abbott Medical Devices2

Top Investigators

Related Conditions

  • Idiopathic Ventricular Tachycardia1
  • Premature Ventricular Contraction1
  • Paroxysmal Atrial Fibrillation1
  • Persistent Atrial Fibrillation1
  • Nonischemic Ventricular Tachycardia1

Activity Timeline